- I-GENE
O2 O
possible O
PCO2 O
slope O
controls O
are O
The O
ventilation O
etoperidone O
rat O
variable O
which O
be O
increase O
nucleotidase I-GENE
should O
neonatal O
Intravenous O
administration O
offer O
acetazolamide O
anhydrase I-GENE
arterial O
effective O
advantages O
carbonic I-GENE
Beta O
), O
dose O
to O
greater O
longer O
significantly O
23 O
appears O
aspects O
and O
our O
no O
alkaline I-GENE
have O
practice O
depleted O
CSF O
pH O
25 O
a O
dichlorphenamide O
( O
Pharmacologic O
CO2 O
use O
-] O
blood O
optimum O
decrease O
standard O
ceased O
HCO3 O
0 O
thus O
rats O
compared O
of O
21 O
at O
daily O
hyperbilirubinemia O
approximated O
Flurazepam O
in O
shown O
endoscopically O
vs O
almost O
being O
p O
phosphatases I-GENE
[ O
mg O
data O
methazolamide O
whenever O
general O
Comparison O
study O
Teratological O
dosage O
important O
When O
agents O
sulthiame O
. O
function O
early O
alveolar O
VCO2 O
Colorectal O
for O
but O
rabbit O
found O
as O
was O
cortical O
) O
/ O
regimen O
on O
removed O
still O
+/- O
drug O
hypnotic O
is O
rise O
an O
inhibitors O
removal O
15 O
polyps O
blocking O
K O
kg O
dependent O
the O
extracorporeal O
night O
with O
1 O
, O
not O
when O
displaced O
HMG I-GENE
production O
induced O
5 I-GENE
